The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Items 801–900 of 1,001
Goffin, J. R., Pond, G. R., Puksa, S., Tremblay, A., Johnston, M. O., Goss, G., Nicholas, G. A., Martel, S., Bhatia, R., Liu, G., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01344-y · Cited by 23
Zhu, M., & Chen, A. (2024) · BMC Public Health · doi:10.1186/s12889-024-18911-1 · Cited by 22
Co‐morbidity and mortality among patients with interstitial lung diseases: A population‐based study
Hilberg, O., Bendstrup, E. M., Løkke, A., Ibsen, R., Fløe, A., & Hyldgaard, C. (2017) · Respirology · doi:10.1111/resp.13234 · Cited by 22
Formiga, M. F., Vital, I., Urdaneta, G., Campos, M., & Cahalin, L. P. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.012 · Cited by 24
Validity of the diagnosis of pneumonia in hospitalised patients with COPD
Finney, L., Padmanaban, V., Todd, S., Ahmed, N., Elkin, S., & Mallia, P. (2019) · ERJ Open Research · doi:10.1183/23120541.00031-2019 · Cited by 22
Zhu, A., Teng, Y., Ge, D., Zhang, X., Hu, M., & Yao, X. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.09.84 · Cited by 22
Yoshimatsu, Y., Tobino, K., Nagami, S., Yagi, N., & Oku, Y. (2020) · International Journal of COPD · doi:10.2147/copd.s257622 · Cited by 22
Kim, J. S., Thomashow, M. A., Yip, N. H., Burkart, K. M., Cascio, C. M. L., Shimbo, D., & Barr, R. G. (2020) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.8.1.2020.0132 · Cited by 22
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Baqdunes, M. W., Leap, J., Young, M., Kaura, A., & Cheema, T. J. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000341 · Cited by 22
Kim, C. Y., Kim, B. K., Kim, Y. J., Lee, S. H., Kim, Y. S., & Kim, J. H. (2021) · International Journal of COPD · doi:10.2147/copd.s276639 · Cited by 22
Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management
Li, L., Han, Y., Zhang, Z., Zhou, W., Fang, H., Qu, J., & Kan, L. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s286315 · Cited by 22
Chronic Obstructive Pulmonary Disease (COPD) and Air Pollution: A Review
Tahery, N., Zarea, K., Cheraghi, M., Hatamzadeh, N., Farhadi, M., Dobaradaran, S., & Mohammadi, M. J. (2021) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.110273 · Cited by 22
Chan, S. M. H., Bernardo, I., Mastronardo, C., Mou, K., Luca, S. N. D., Seow, H. J., Dobric, A., Brassington, K., Selemidis, S., Bozinovski, S., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15482 · Cited by 21
Tejwani, V., Fawzy, A., Putcha, N., Castaldi, P. J., Cho, M. H., Pratte, K., Bhatt, S. P., Lynch, D. A., Humphries, S. M., Kinney, G. L., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.05.007 · Cited by 22
Chen, L., Chen, L., Zheng, H., Wu, S., & Wang, S. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01624-1 · Cited by 22
Sato, R., Hasegawa, D., Nishida, K., Takahashi, K., Schleicher, M. C., & Chaisson, N. F. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.09.041 · Cited by 22
β Agonist Delivery by High-Flow Nasal Cannula During COPD Exacerbation
Beuvon, C., Coudroy, R., Bardin, J., Marjanovic, N. S., Rault, C. C. S., Bironneau, V., Drouot, X., Robert, R., Thille, A. W., & Frat, J. (2021) · Respiratory Care · doi:10.4187/respcare.09242 · Cited by 22
Li, L., Huang, H., Song, J., Yu, Y., Jia, Y., Wang, Y., Dang, X., Huang, L. F., & Liu, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.806025 · Cited by 22
Kotlyarov, S. N. (2022) · BioMolecular Concepts · doi:10.1515/bmc-2022-0001 · Cited by 22
An identifiable model of lung mechanics to diagnose and monitor COPD
Lerios, T., Knopp, J. L., Holder-Pearson, L. R., Guy, E. F. S., & Chase, J. G. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106430 · Cited by 22
MacDonald, M., Polkinghorne, K. R., MacDonald, C. J., Leong, P., Hamza, K., Kathriachchige, G., Osadnik, C. R., King, P. T., & Bardin, P. G. (2023) · Respirology · doi:10.1111/resp.14534 · Cited by 22
Zhang, J., Qin, Y., Zhou, C., Luo, Y., Wei, H., Ge, H., Liu, H., Zhang, J., Li, X., Pan, P., et al. (2023) · International Journal of COPD · doi:10.2147/copd.s412106 · Cited by 22
Sex related differences in muscle health and metabolism in chronic obstructive pulmonary disease
ENGELEN, M. P. K. J., Kirschner, S. K., Coyle, K. S., Argyelan, D., Neal, G., Dasarathy, S., & Deutz, N. E. P. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.031 · Cited by 22
Phenotyping COPD exacerbations using imaging and blood-based biomarkers
Alotaibi, N. M., Chen, V., Hollander, Z., Hague, C. J., Murphy, D. T., Leipsic, J. A., DeMarco, M. L., FitzGerald, J. M., McManus, B. M., Ng, R. T., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s152484 · Cited by 22
Self-citationInhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD
Donner, C. F., Amaducci, S., Bacci, E., Baldacci, S., Bartoli, M. L., Beghi, G. M., Benfante, A., Brighindi, S., Casali, L., Castiglia, D., et al. (2018) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2018.886 · Cited by 21
Two risk factors for depression in chronic obstructive pulmonary disease
Xu, K., & Xiu, L. (2018) · Medical Science Monitor · doi:10.12659/msm.904969 · Cited by 24
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer
Kuemmel, A., Alflen, A., Schmidt, L. H., Sebastian, M., Wiewrodt, R. G., Schulze, A. B., Buhl, R., & Radsak, M. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-28971-0 · Cited by 22
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
Oshagbemi, O. A., Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. �., der Zee, A. H. M., Burden, A. M., & de Vries, F. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4655 · Cited by 22
Oshagbemi, O. A., Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. �., der Zee, A. H. M., Driessen, J. H. M., & de Vries, F. (2019) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2019.1608172 · Cited by 22
Airflow Obstruction and Cardio-metabolic Comorbidities
Triest, F. J. J., Studnicka, M., Franssen, F. M. E., Vollmer, W. M., Lamprecht, B., Wouters, E. F. �., Burney, P., & Vanfleteren, L. E. G. W. (2019) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2019.1614550 · Cited by 22
Simonÿ, C., Riber, C., Bødtger, U. C. S., & Birkelund, R. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16183320 · Cited by 22
Chen, J. W., Kaye, L., Tuffli, M., Barrett, M., Jones-Ford, S., Shenouda, T., Gondalia, R., Henderson, K., Combs, V., Sickle, D. V., et al. (2019) · JMIR Formative Research · doi:10.2196/13286 · Cited by 22
Redolfi, S., Grassion, L., Rivals, I., Chávez, M., Wattiez, N., Arnulf, I., Gonzalez‐Bermejo, J., & Similowski, T. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1312oc · Cited by 22
Kaculini, C., Wallace, D. J., Haywood, A., Michalek, J. E., Mascitelli, J. R., Seifi, A., & Grandhi, R. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa242 · Cited by 22
Kinjo, T., Kitaguchi, Y., Droma, Y., Yasuo, M., Wada, Y., Ueno, F., Ôta, M., & Hanaoka, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69184-8 · Cited by 23
Validation of a Prediction Score for Drug-Resistant Microorganisms in Community-acquired Pneumonia
Ceccato, A., Méndez, R., Ewig, S., de la Torre, M. C., Cillóniz, C., Gabarrús, A., Prina, E., Ranzani, O., Ferrer, M., Almirall, J., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-558oc · Cited by 22
Qin, J., Wang, G., Liao, Y., Shang, W., & Han, D. H. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01480-w · Cited by 21
Kyomoto, Y., Kanazawa, H., Tochino, Y., Watanabe, T., Asai, K., & Kawaguchi, T. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.007 · Cited by 21
Messineo, L., Lonni, S., Magri, R., Pedroni, L., Taranto‐Montemurro, L., Corda, L., & Tantucci, C. (2019) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2019.103315 · Cited by 21
Szylińska, A., Rotter, I., Listewnik, M. J., Lechowicz, K., Brykczyński, M., Dzidek, S., Żukowski, M., & Kotfis, K. (2020) · Medicina · doi:10.3390/medicina56070342 · Cited by 21
Rezaei, A., Fakharian, A., Ghorbani, F., Idani, ., Abedini, A., & Jamaati, H. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13315 · Cited by 21
Hanafi, N. S., Agarwal, D. M., Chippagiri, S., Brakema, E. A., Pinnock, H., Sheikh, A., Liew, S.-M., Ng, C., Isaac, R., Chinna, K., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.04026 · Cited by 21
Chen, L., & Chen, S. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01692-3 · Cited by 21
Interstitial Lung Abnormalities, Emphysema, and Spirometry in Smokers
Menon, A. A., Putman, R. K., Sanders, J. L., Hino, T., Hata, A., Nishino, M., Ghosh, A., Ash, S. Y., Rosas, I. O., Cho, M. H., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.10.034 · Cited by 23
Hao, W., Lin, F., Shi, H., Guan, Z., & Jiang, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.2000199 · Cited by 21
Hawthorne, G., Richardson, M., Greening, N. J., Esliger, D., Briggs‐Price, S., Chaplin, E., Clinch, L., STEINER, M. C., Singh, S. J., & Orme, M. W. (2022) · Respiratory Research · doi:10.1186/s12931-022-02018-5 · Cited by 19
Yamada, Y., Chubachi, S., Yamada, M., Yokoyama, Y., Tanabe, A., Matsuoka, S., Niijima, Y., Murata, M., Fukunaga, K., & Jinzaki, M. (2022) · Respiration · doi:10.1159/000527067 · Cited by 21
Dai, Z., Liu, X., Zeng, H., & Chen, Y. (2022) · Respiratory Research · doi:10.1186/s12931-022-02234-z · Cited by 21
Liu, X., Ma, Y., Luo, L., Zeng, Z., Zong, D., & Chen, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109577 · Cited by 21
Lee, S. H., Kim, J., Kim, N. H., Kim, O., Shon, C.-H., Kim, S. J., Jang, Y., Yun, S., Lim, S. E., Jung, S. Y., et al. (2023) · Thorax · doi:10.1136/thorax-2021-217923 · Cited by 22
Li, J., Yang, L., Yao, Y., Gu, P., Xie, Y., Yin, H., Xue, M., Jiang, Y., Dai, J., & Ma, J. (2024) · BMC Medicine · doi:10.1186/s12916-023-03240-8 · Cited by 25
What do polymorphisms tell us about the mechanisms of COPD?
Li, Y., Cho, M. H., & Zhou, X. (2017) · Clinical Science · doi:10.1042/cs20160718 · Cited by 20
Su, V. Y., Liao, H.-F., Perng, D., Chou, Y., Hsu, C., Chou, C.-L., Chang, Y.-L., Yen, J., Chen, T., & Chou, T.-C. (2018) · International Journal of COPD · doi:10.2147/copd.s157761 · Cited by 21
Huprikar, N., Holley, A. B., Skabelund, A. J., Hayes, J. A., Hiles, P. D., Aden, J. K., Morris, M. J., & Hersh, A. M. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201805-317oc · Cited by 21
Verhamme, F. M., Smet, E. G. D., Hooste, W. V., Delanghe, J., Verleden, S. E., Joos, G., Brusselle, G., & Bracke, K. R. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0116-2 · Cited by 21
Zuo, H., Cattani‐Cavalieri, I., Valença, S. S., Musheshe, N., & Schmidt, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14605 · Cited by 21
Risk stratification for short‐term mortality at hospital admission for acute exacerbations of COPD
Sprooten, R. T. M., Rohde, G. G. U., Lawyer, G., Leijte, W. T., Wouters, E. F. �., & Franssen, F. M. E. (2019) · Respirology · doi:10.1111/resp.13538 · Cited by 21
Effects of Pulmonary Rehabilitation on Gait Characteristics in Patients with COPD
Liu, W.-Y., Meijer, K., Delbressine, J. M., Willems, P. J. B., Wouters, E. F. �., & Spruit, M. A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040459 · Cited by 21
Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis
Yoon, H., Park, S. Y., Lee, C., Byun, M. K., Na, J. O., Lee, J., Lee, W., Yoo, K. H., Jung, K.-S., & Lee, J. H. (2019) · International Journal of COPD · doi:10.2147/copd.s205517 · Cited by 23
Suzuki, Y., Inui, N., Karayama, M., Imokawa, S., Yamada, T., Yokomura, K., Asada, K., Kusagaya, H., Kaida, Y., Matsuda, H., et al. (2019) · International Journal of COPD · doi:10.2147/copd.s214610 · Cited by 23
Blanco, I., Valeiro, B., Torres‐Castro, R., Barberán-García, A., Torralba, Y., Moisés, J., Sebastián, L., Osorio, J., Ríos, J., Gimeno‐Santos, E., et al. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.10.015 · Cited by 21
Aissa, S., Knaz, A., Maatoug, J., Khedher, A., Benzarti, W., Abdelghani, A., Garrouche, A., Hayouni, A., Benzarti, M., Gargouri, I., et al. (2020) · BioMed Research International · doi:10.1155/2020/1031845 · Cited by 21
Effects of a human microenvironment on the differentiation of human myoblasts
Catteau, M., Gouzi, F., Blervaque, L., Passerieux, E., Blaquière, M., Ayoub, B., Bughin, F., Mercier, J. G., Hayot, M., & Pomiès, P. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.020 · Cited by 22
Poh, T. Y., Tiew, P. Y., Lim, A. Y. H., Thng, K. X., Ali, N. A. B. M., Narayana, J. K., Aogáin, M. M., Tien, Z., Chew, W. M., Chan, A., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.048 · Cited by 21
Tamaki, K., Sakihara, E., Miyata, H., Hirahara, N., Kirichek, O., Tawara, R., Akiyama, S., Katsumata, M., Haruya, M., Ishii, T., et al. (2021) · International Journal of COPD · doi:10.2147/copd.s302259 · Cited by 21
Wortley, M. A., Birrell, M. A., & Belvisi, M. G. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_63 · Cited by 21
Jarosch, I., Hitzl, W., Koczulla, A. R., Wencker, M., Welte, T., Gloeckl, R., Janciauskiene, S. M., & Kenn, K. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.009 · Cited by 21
Ye, L., Mao, S., Fang, S., Zhang, J., Tan, Y. L., & Gu, W. (2019) · Inflammation · doi:10.1007/s10753-019-01017-x · Cited by 21
Frailty, Comorbidity, and COPD
Charbek, E., Espiritu, J. R. D., Nayak, R. P., & Morley, J. E. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1068-7 · Cited by 22
Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study
Zhou, L., Yang, H., Zhang, Y., Wang, Y., Zhou, X., Liu, T., Yang, Q., & Wang, Y. (2023) · Thorax · doi:10.1136/thorax-2023-220703 · Cited by 20
Jiang, W., Jin, X., Du, C., Gu, W., Gao, X., Zhou, C., Tu, C., Chen, H., Li, H., Shen, Y., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102518 · Cited by 20
Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores
Miravitlles, M., Molina, J., Quintano, J. A., Campuzano, A., Pérez, J., & Roncero, C. (2018) · International Journal of COPD · doi:10.2147/copd.s154791 · Cited by 20
van Geffen, W. H., & Kerstjens, H. A. M. (2018) · International Journal of COPD · doi:10.2147/copd.s154878 · Cited by 21
Kumar, A., Schwarz, D., Acharya, B., Agrawal, P. K. B., Aryal, A., Choudhury, N., Citrin, D., Dangal, B., Deukmedjian, G., Dhimal, M., et al. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001343 · Cited by 20
Radovanovic, D., Contoli, M., Marco, F. D., Sotgiu, G., Pelaia, G., Braido, F., Corsico, A. G., Micheletto, C., Rogliani, P., Scichilone, N., et al. (2019) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2019.1659760 · Cited by 20
Bachmann, M. O., Bateman, E. D., Stelmach, R., Cruz, Á. A., de Andrade, M. P., Zonta, R., Zepeda, J., Natal, S., Cornick, R. V., Wattrus, C., et al. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2019-001921 · Cited by 18
Arimura‐Omori, M., Kiyohara, C., Yanagihara, T., Yamamoto, Y., Ogata-Suetsugu, S., Harada, E., Hamada, N., Tsuda, T., Takata, S., Shimabukuro, I., et al. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.3.667 · Cited by 19
Hu, H., Xu, L., Gao, H., Lv, H., Huang, M., Fang, K., Wang, S., Zhao, B., Ren, D., Wang, X., et al. (2020) · Planta Medica · doi:10.1055/a-1197-7019 · Cited by 20
Huber, M. B., Kurz, C., Kirsch, F. W., Schwarzkopf, L., Schramm, A., & Leidl, R. (2020) · Respiratory Research · doi:10.1186/s12931-020-01556-0 · Cited by 21
Tu, Y.-H., Guo, Y. H., Ji, S., Shen, J., & Fei, G.-H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.604590 · Cited by 20
Liu, K., Yu, X., Cui, X., Su, Y., Sun, L., Yang, J., & Han, W. (2021) · International Journal of COPD · doi:10.2147/copd.s300569 · Cited by 20
González-García, M., Barrero, M., & Maldonado, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.668144 · Cited by 20
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
Kellerer, C., Jörres, R. A., Schneider, A., Alter, P. J., Kauczor, H., Jobst, B. J., Biederer, J., Bals, R., Watz, H., Behr, J., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01837-2 · Cited by 20
Self-citationZhang, D., Zhang, H., Li, X., Lei, S., Wang, L., Guo, W., & Li, J. (2021) · International Journal of COPD · doi:10.2147/copd.s338074 · Cited by 20
He, G., Dong, T., Yang, Z., Branstad, A., Huang, L., & Jiang, Z. (2022) · The Analyst · doi:10.1039/d1an01702k · Cited by 20
Kozłowska, N., Wierzbicka, M., Jasiński, T., & Domino, M. (2022) · Animals · doi:10.3390/ani12030381 · Cited by 20
Tanaka, K., Shiota, S., Sakakibara, O., Shimoda, M., Takafuji, A., Takabatake, M., Kadota, Y., Kawakami, T., Suzuki, S., & Kawahara, M. (2022) · Biomolecules · doi:10.3390/biom12040583 · Cited by 20
Chronic Obstructive Pulmonary Disease and Heart Failure
Pellicori, P., Cleland, J. G. F., & Clark, A. L. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2021.12.005 · Cited by 20
Ma, A., Wang, G., Du, Y., Guo, W., Guo, J., Hu, Y. P., Bai, D., Huang, H., Zhuang, L., Chen, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902955 · Cited by 20
Valeiro, B., Rodríguez, E., Pérez, P., Gómez, A., Mayer, A. I., Pasarin, A., Ibáñez, J., Ferrer, J., & Ramón, M. A. (2022) · Respirology · doi:10.1111/resp.14394 · Cited by 22
Voulgaris, A., Archontogeorgis, K., Anevlavis, S., Fanaridis, M., Froudarakis, Μ. E., Schiza, S., & Steiropoulos, P. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13580 · Cited by 21
Luca, S. N. D., Chan, S. M. H., Dobric, A., Wang, H., Seow, H. J., Brassington, K., Mou, K., Alateeq, R., Akhtar, A., Bozinovski, S., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.005 · Cited by 20
SIRT1 as a Potential Therapeutic Target for Chronic Obstructive Pulmonary Disease
Li, S., Huang, Q., & He, B. (2023) · Lung · doi:10.1007/s00408-023-00607-9 · Cited by 20
cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features
Nourian, Y. H., Salimian, J., Ahmadi, A., Salehi, Z., Karimi, M., Emamvirdizadeh, A., Jamalkandi, S. A., & Ghanei, M. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101438 · Cited by 21
Akbaş, T., & Güneş, H. (2023) · Acute and Critical Care · doi:10.4266/acc.2022.01011 · Cited by 20
Lin, L., Liu, C., Cheng, W., Song, Q., Zeng, Y., Li, X., Deng, D., Liu, D., Chen, Y., Cai, S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1147985 · Cited by 20
Zhang, W., Wang, J., Chen, B., Ji, X., Chen, Z., Chen, M., Liao, S., Jiang, S., Pan, Z., Wang, W., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131550 · Cited by 20
Ma, C., Liao, K., Wang, J., Li, T., & Liu, L. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00994-9 · Cited by 20
Ichikado, K., Kotani, T., Kondoh, Y., Imanaka, H., Johkoh, T., Fujimoto, K., Nunomiya, S., Kawayama, T., Sawada, M., Jenkins, E., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03451-z · Cited by 20
Long-term exposure to PM10 and respiratory health among Parisian subway workers
Canu, I. G., Wild, P. P., Charreau, T., Freund, R., Toto, A., Pralong, J. A., Sakthithasan, K., Jouannique, V., Debatisse, A., & Suárez, G. (2023) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2023.114316 · Cited by 20
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review